Application
Antibodies tested include p-PKC δ (H-9): (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC δ (Ser 645)-R: (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC δ (Tyr 155)-R: (A,B,C) and PKC δ (C-20): (D,E,F).
Application
Antibodies tested include p-PKC δ (Tyr 565)-R: (A,B,C) and PKC δ (C-20): (D,E,F).
Application
Antibodies tested include p-PKC δ (F-7): (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC δ (Thr 507)-R: (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC βIl/δ (E-7): (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC βIl/δ (Ser 660)-R: (A,B) and PKC δ (C-20): (C,D).
Application
Antibodies tested include p-PKC δ (Tyr 311)-R: (A,B,C) and PKC δ (C-20): (D,E,F).
Application
Western blot analysis of PKC δ expression in non-transfected 293T: (A), mouse PKC δ transfected 293T: (B) and NIH/3T3 (C) whole cell lysates.
Application
Immunoperoxidase staining of formalin fixed, paraffin-embedded human tonsil tissue showing cytoplasmic and membrane staining of lymphoid cells and squamous epithelial cells at low (A) and high (B) magnification. Kindly provided by The Swedish Human Protein Atlas (HPA) program.
Application
Western blot analysis of PKC δ expression in non-transfected control (A) and PKC δ siRNA transfected (B) Jurkat cells. Blot probed with PKC δ (C-20): . GAPDH (FL-335): used as specificity and loading control.
Application
Antibodies tested include PKC δ (C-17): (A) and PKC δ (C-20): (B-E).
Application
Blots were probed with p-PKC δ (Thr 507)-R: (A,B) and PKC δ (C-20)-G: (C,D).
Application
Immunofluorescence staining of methanol-fixed A-431 cells showing cytoplasmic staining.
Application
Western blot analysis of PKC δ expression in A-431 whole cell lysate.